Biomarin Pharmaceutical Inc. (BMRN)
NASDAQ · Healthcare
Biomarin Pharmaceutical Inc. Revenue 2008–2025
Biomarin Pharmaceutical Inc. annual/quarterly revenue history and growth rate from 2008 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Biomarin Pharmaceutical Inc. revenue for the quarter ending March 31, 2026 was 766.2 M, a 2.83% increase year-over-year.
- Biomarin Pharmaceutical Inc. revenue for the twelve months ending March 31, 2026 was 3.1 B, a 15.81% increase year-over-year.
- Biomarin Pharmaceutical Inc. annual revenue for 2025 was 3.2 B, a 12.87% increase from 2024.
- Biomarin Pharmaceutical Inc. annual revenue for 2024 was 2.9 B, a 17.97% increase from 2023.
- Biomarin Pharmaceutical Inc. annual revenue for 2023 was 2.4 B, a 15.42% increase from 2022.
- Biomarin Pharmaceutical Inc. annual revenue for 2022 was 2.1 B.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Biomarin Pharmaceutical Inc. Market Cap — FAQ
Biomarin Pharmaceutical Inc. (BMRN) market cap over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BMRN's market cap history?
The chart and table above show Biomarin Pharmaceutical Inc.'s market cap by year and by quarter, including the growth rate.